ARCHIVES

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

This article is from The Cancer Letter archive.

Vol. 01 No. 39 | November 1, 1974

Download PDF Visit The Full Archive

Related Articles

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

Final stats On FY92 Budget; Success Rate Was 35 Percent

December 4, 1992

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

In Brief: Des Exposed Women Face New Risk: Unfavorable Pregnancies; Hutchinson Labor Election Set

March 21, 1980

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996